ABMD Stock Forecast: ABMD Is Up More Than 94% In a Year

Viktoria VoronchukThis ABMD stock prediction article was written by Viktoriya Voronchuk – Financial Analyst intern I Know First.

Summary:

  • Since the beginning of 2020, the company's share has risen by 94%.
  • The revenue growth is forecasted to 16.3% per year - faster than the US market.
  • The DCF analysis shows that the ABMD stock forecast should be around $399.63.

premiumRead The FullPremium Article

Subscribe to receive exclusive PREMIUM content here

I Know First Evaluation Report For Bitcoin Forecast Performance 2020

Bitcoin Forecasts Highlights:

  • The best returns were obtained in the 3-months time horizon, providing an average return of 14.30% for USD / BTC and 17.93% for BTC / EUR.
  • The best hit ratios were similarly obtained for the 3-months time horizon, with the best hit ratio being 78.77% for USD / BTC and 77.65% for BTC / EUR.
  • The forecast accuracy has increased by an average of 9% over intervals of 3 to 14 days, 3% in 3 months horizon, compared to the previous year.

Read more

Coronavirus Stock Market: New Opportunities Rise With the Vaccine

This article was written by Gabriel Plat, a Financial Analyst at I Know First.

Summary:

  • The vaccine is closer than we thought. Pfizer and BioNTech plan to distribute it by 2021;
  • AHT grew 228% in 3 days, indicating opportunities that might be available when the pandemic is over;
  • The entertainment and flight industries can be a huge opportunity to look at;
  • I Know First algorithm is the best way to maximize your profit amid these opportunities.

premiumRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content here

NVAX Stock Forecast: Global Rollout Of Covid-19 Vaccines & Buy Rating

Viktoria VoronchukThis NVAX stock prediction article was written by Viktoriya Voronchuk – Financial Analyst intern I Know First.

Summary:

  • Over the past month, the NVAX stock is up 69%: Investors believe Novavax is a major competitor for the vaccine from covid-19
  • Novavax spent 113,84 thousand $ on research and development: more than competitors in the biotech sector
  • The average growth rate for the last 8 years shows that NVAX 's stock target price should be around 145.15 $ for the next year

premiumRead The FullPremium Article

Subscribe to receive exclusive PREMIUM content here

Winning Stock Forecast: CCL, KSS, MT Bounced Hard in 3 Days

Kohl’s  partnership with Sephora shops – 27.02 % increase in 3 days

(Source: www.wpxi.com)

On December 4, I Know First issued a 3-days winning stock forecast for KSS with a strong bullish signal of 0.29 and the predictability of 0.22. 3 days later, KSS stock rose from $36.52 to $40.90. This 27.02% surge was in line with our forecast.

Kohl’s holds the No. 2 ranks among its peers in the Retail-Department Stores industry group in the United States. The main reason for the rise in Kohl’s stock is a long-term strategic partnership with Sephora shops. Sephora is a popular prestige brand and a proven traffic driver. The companies said that the new partnership, “Sephora at

Read More

CCL Stock Prediction: Long Way to Recovery but Brightness is Ahead

motek 1The stock prediction article was written by Tianyue Yu, Analyst at I Know First, Master's candidate at Brandeis University.

Summary:

  • Costa and AIDA fleet resumption spurred market confidence.
  • CCL remains well-positioned to win the post-pandemic market.
  • Stock is currently traded at fair value but the bull case shows upside till $46.

ccl stock forecastRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here

MHK Stock Prediction: A Low Valuation Stock with Great Potential

motek 1The stock prediction article was written by Tianyue Yu, Analyst at I Know First, Master's candidate at Brandeis University.

Summary:

  • Q3 encouraging results indicate the margin level rebounded.
  • Favorable housing market trend will be the revenue driver.
  • EPS estimation show potential upside from the current price.

SQ stock forecastRead The Full Premium Article

Subscribe to receive exclusive PREMIUM content Here